Vault-13

LAVA THERAPEUTICS NV LVTX

SHS · Common Stock · CUSIP N51517105

0 institutional holders -21 vs Q3 2025
—reported value*
0 new 0 added 0 reduced 20 sold out net sold ≈ $16.1m (-10.3m shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.

Trends to Q4 2025

Institutional holders

Managers reporting a position, each quarter

0102030Q3 22: 14Q4 22: 21Q1 23: 20Q2 23: 16Q3 23: 15Q4 23: 15Q1 24: 21Q2 24: 20Q3 24: 22Q4 24: 23Q1 25: 21Q2 25: 20Q3 25: 21Q4 25: 00Q3 22Q2 23Q1 24Q4 24Q4 25
Numbers
QuarterHolders
Q3 202214
Q4 202221
Q1 202320
Q2 202316
Q3 202315
Q4 202315
Q1 202421
Q2 202420
Q3 202422
Q4 202423
Q1 202521
Q2 202520
Q3 202521
Q4 20250

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
20020Q1 24: 12 bought or addedQ1 24: 7 cut or sold outQ2 24: 7 bought or addedQ2 24: 8 cut or sold outQ2 24Q3 24: 7 bought or addedQ3 24: 9 cut or sold outQ4 24: 9 bought or addedQ4 24: 10 cut or sold outQ4 24Q1 25: 8 bought or addedQ1 25: 11 cut or sold outQ2 25: 7 bought or addedQ2 25: 8 cut or sold outQ2 25Q3 25: 9 bought or addedQ3 25: 7 cut or sold outQ4 25: 0 bought or addedQ4 25: 20 cut or sold outQ4 25
Numbers
QuarterBought or addedCut or sold out
Q1 2024127
Q2 202478
Q3 202479
Q4 2024910
Q1 2025811
Q2 202578
Q3 202597
Q4 2025020

Calls vs puts

Options held, notional value, last 4 quarters. P/C = puts ÷ calls

CallsPuts
$0$100k$200k$300kQ1 25 calls: $67.6kQ1 25 puts: $0Q1 25P/C 0.00Q2 25 calls: $27.6kQ2 25 puts: $0Q2 25P/C 0.00Q3 25 calls: $226.4kQ3 25 puts: $87.5kQ3 25P/C 0.39Q4 25 calls: $0Q4 25 puts: $0Q4 25P/C —
Numbers
QuarterCallsPutsP/C
Q1 2025$67.6k$00.00
Q2 2025$27.6k$00.00
Q3 2025$226.4k$87.5k0.39
Q4 2025$0$0—

Biggest buyers

None

Biggest sellers

Shay Capital LLC Sold out -2,548,730-2.5m
Redmile Group, LLC Sold out -2,074,372-2.1m
BML Capital Management, LLC Sold out -1,970,610-2.0m
Sanofi Sold out -1,919,455-1.9m
Merck & Co., Inc. Sold out -1,149,345-1.1m
GTS SECURITIES LLC Sold out -200,000-200.0k
Rangeley Capital, LLC Sold out -165,000-165.0k
PNC Financial Services Group, Inc. Sold out -65,000-65.0k
CITADEL ADVISORS LLC Sold out -53,308-53.3k
ROYAL BANK OF CANADA Sold out -44,348-44.3k

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
Shay Capital LLC 13G · passive investor new · filed 2025-09-26 9.9% new 2.6m 2025-09-26
BML Investment Partners, L.P. 13G · passive investor new · filed 2025-03-03 7.4% new 2.0m 2025-03-03

Holders, Q4 2025

#ManagerLocationShares Value% of their portfolioChangeShares change